Two new analysts’ votes on the share of Shop Apotheke Europe. Jefferies still has a buy recommendation for the online pharmacy. You can see the target price for the designated MDAX climber still at 120 euros – which, interestingly, is listed slightly below the Friday closing price of 127.60 euros (-2.3 percent) despite the buy recommendation. Of particular interest will be the vote on a legislative proposal in Germany that is intended to strengthen the position of local pharmacies. There is potential here that the growth prospects of Shop Apotheke Europe will be adversely affected. The experts assume that the Bundestag will vote on the law by the end of November at the latest.
Kepler Cheuvreux has also issued a buy recommendation for the Shop Apotheke Europe share – albeit with a target price of 192 euros, which is well above the current share price. Merger speculation and the introduction of the e-prescription are given as reasons. It was not surprising, however, that the Zur Rose competition emphasized that a merger was not an issue.
A quick look at the chart technique of the title: After the consolidation of the Shop Apotheke Europe share from the house top at 166.40 euros on Tuesday to 117.00 euros, the last few days were characterized by a sideways movement. While the zones at 117.00 / 120.20 euros and 122.40 / 123.40 euros have shown themselves to be supportive, resistance from these days can be found between 131.40 / 132.80 euros and 135 euros. An area at 115.00 / 115.40 euros also complements the support zones. Brand breaks should be used as procyclical trading signals for the Shop Apotheke Europe share.
Important technical data on the Shop Apotheke Europe share:
Last share price: 127.60 euros (exchange: XETRA – Frankfurt)
Bollinger Bands 20 (bottom / top): 119.10 euros / 174.20 euros
EMA 20: 146.60 euros
EMA 50: 133.50 euros
EMA 200: 92.80 euros
At a glance – chart and news: Shop Apotheke Europe